StonvexLoading…
StonvexStonvexStonvexCore line items from SLGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $3.80M | $3.80M | $0.00 | $3.30M |
Operating Income | $-7.54M | $-12.01M | $-16.24M | $2.96M |
Net Income | $-6.13M | $-10.58M | $-14.92M | $3.22M |
EPS (Diluted) | $-2.19 | $-3.79 | $-0.65 | $0.14 |
Total Assets | $29.92M | $35.85M | $46.63M | $69.19M |
Total Liabilities | $7.11M | $7.00M | $4.42M | $13.60M |
Cash & Equivalents | $11.03M | $19.49M | $12.45M | $20.09M |
Free Cash Flow OCF − CapEx | $275.00K | $-13.89M | $-9.65M | $-7.83M |
Shares Outstanding | 2.79M | 2.79M | 23.13M | 23.13M |